Ac immune announces upcoming presentations at the alzheimer's association international conference

Lausanne, switzerland, july 22, 2022 (globe newswire) -- ac immune sa (nasdaq: aciu), a swiss-based, clinical-stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, today announced 10 upcoming presentations that will be delivered at the alzheimer's association international conference (aaic) in san diego, california (united states) and online, july 31 – august 4, 2022.
ACIU Ratings Summary
ACIU Quant Ranking